SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE:A) today introduced SureGuide, the first in a new series of kits to advance genome editing and synthetic biology.
The complete SureGuide workflow includes a SureGuide Cas9 Nuclease Kit, SureGuide gRNA Synthesis Kit and SureGuide gRNA Control Kit, all designed to work together for any lab interested in quickly enabling next-generation genome engineering. The workflow represents the first integrated solution for in-vitro CRISPR/Cas9 experiments, with gRNA design and gRNA synthesis, and is available as a kit or as individual components.
Hey, check out all the research scientist jobs. Post your resume today!
